Efficacy of aprotinin as a blood conservation technique for adult deformity spinal surgery: A retrospective study

Spine

Volumn 33, Issue 16, 2008, Pages 1775-1781

  Tayyab, Neil Arif ^a,b   Mariller, Marjorie M ^a   Rivlin, Michael ^c   Berekashvili, Ketevan ^a   Bitan, Fabien D ^a,d   Casden, Andrew M ^a   Kuflik, Paul ^a   Neuwirth, Michael G ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b Girard Orthopaedic Surgeons la Jolla   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Manhattan Orthopaedics   (United States)

Author keywords

Adult deformity; Aprotinin; Blood conservation technique; Blood loss; Complications; Scoliosis; Spine surgery; Transfusion; Trasylol

Indexed keywords

APROTININ; HEMOSTATIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD CONSERVATION; BLOOD TRANSFUSION; CONTROL GROUP; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HEART DISEASE; HEMATOMA; HUMAN; KIDNEY DISEASE; KYPHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCOLIOSIS; SIDE EFFECT; SPINE FUSION; SPINE MALFORMATION; SPINE SURGERY; STROKE; TACHYCARDIA; UREA NITROGEN BLOOD LEVEL; WOUND INFECTION; ADOLESCENT; COMPARATIVE STUDY; CONGENITAL MALFORMATION; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; SPINAL CORD; SPINAL CORD DISEASE;

ADOLESCENT; ADULT; AGED; APROTININ; BLOOD LOSS, SURGICAL; FEMALE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPINAL CORD; SPINAL CORD DISEASES; SPINAL FUSION;

EID: 58149120966     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31817b87c4     Document Type: Article

References (24)

1. Available at: http://www.pathology.unc.edu/labs/textfiles/tms-risk.htm# infectious.
2. Royston D, Bistrup BP, Taylor KM, et al. Effects of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987;2:1289-91.
3. Janssens M, Joris J, David JL, et al. High-dose aprotininreduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology 1994;80: 23-9.
4. Murkin JM, Shannon NA, Bourne RB, et al. Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty. Anesth Analg 1995;80:343-8.
5. Murkin JM, Haig GM, Beer KJ, et al. Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement. J Bone Joint Surg Am 2000;82:675-84.
6. Jeserschek R, Clar H, Aigner C, et al. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery: a prospective, double-blind, randomized and placebo-controlled study. J Bone Joint Surg Br 2003;85:174-7.
7. Capdevila X, Calvert Y, Biboulet P, et al. Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery. Anesthiology 1998;88:50-7.
8. Hayes A, Murphy DB, McCarroll M. The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery. J Clin Anesth 1996;8:357-60.
9. Kasper SM, Eisner F, Hilgers D, et al. A retrospective study of the effects of small-dose aprotinin on blood loss and transfusion needs during total hip arthroplasty. Eur J Anaesthesiol 1998;15:669-75.
10. Thorpe CM, Murphy WG, Logan M. Use of aprotinin in knee replacement surgery. Br J Anaesth 1994;73:408-10.
11. Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothor Vasc Anesth 1992;6:76-100.
12. Landis RC, Asimakopoulos G, Poullis M, et al. The anti-thrombotic and anti-inflammatory mechanisms of action of aprotinin. Ann Thorac Surg 2001;72:2169-75.
13. Landis RC, Haskard DO, Taylor KM. New anti-inflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg 2001;72:S1808-S1813.
14. Lentschener C, Cottin P, Bouaziz H, et al. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg 1999;89:590-7.
15. Urban MK, Beckman J, Gordon M, et al. The efficacy of antifibrinolytic in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 2001;26:1152-6.
16. Karapurkar A, Kudalkar A, Naik L. Aprotinin to reduce perioperative blood loss in scoliosis surgery. Indian J Anaesth 2002;46:378-80.
17. Cole JW, Murray DJ, Snider RJ, et al. Aprotinin reduces blood loss during spinal surgery in children. Spine 2003;28:2482-5.
18. Khoshhal K,Mukhtar I, Clark P, et al. Efficacy of aprotinin in reducing blood loss in spinal fusion for idiopathic scoliosis. J Fed Orthopaed 2003;23: 661-4.
19. Edler AE, Murray DJ, Forbes RB. The role of neuromusculardisease as a cause of bleeding during scoliosis surgery. Anesthesiology 1999;91:A1254.
20. Dietrich W, Spath P, Zuuhlsdorf M, et al. Anaphylactic rections to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology 2001;95:64-71; discussion 5A-6A.
21. Murkin JM. Attenuation of neuologic injury during cardiac surgery. Ann Thrac Surg 2001;72:S1838-S1844.
22. Haas S. Aprotinin-a blood-saving substance. Infusionsther Transfusionsmed 2002;29:151-5.
23. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65.
24. Okubadejo GO, Bridwell KH, Lenke LG, et al. Aprotinin Decreases Blood Loss in Complex Adult Spinal Deformity but Increases the Risk of Acute Renal Failure. Presented at 41st Scoliosis Research Society Scientific Meeting. Montaray, USA; 2006.